Criteria for genetic testing of men with prostate cancer misses those with mutations who could be treated
Men with prostate cancer who were not eligible for germline (hereditary) genetic testing were just as likely to carry pathogenic variants that could be treated as men who were eligible for this testing, according to a new study funded by a genetics testing company. And men who identified as non-White (mainly Black) men who did …